Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/jamanetworkopen.2019.7840 | DOI Listing |
Eval Rev
January 2025
School of Economics and Management, Taiyuan University of Science and Technology, Taiyuan, China.
Performance management in university-based scientific research institutions is essential for driving reform, advancing education quality, and fostering innovation. However, current performance evaluation models often focus solely on research indicators, neglecting the critical interdependence between the education and research systems. This oversight leads to inefficiencies in resource allocation and an underestimation of overall institutional performance, particularly in universities with varying development levels.
View Article and Find Full Text PDFFront Immunol
January 2025
Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Objectives: Traditional methods of treating allergies primarily revolve around avoiding allergens and promptly using rescue medications when allergic symptoms occur. However, this approach is known for its inefficiency and limited success in achieving long-term relief. Our aim was to conduct a comprehensive analysis of previously published randomized controlled trials (RCTs) that explore the effectiveness and safety of epicutaneous immunotherapy (EPIT) as a means to manage food allergies in children.
View Article and Find Full Text PDFBMC Oral Health
December 2024
NIHR Applied Research Collaborative Greater Manchester (NIHR ARC GM), University of Manchester, Manchester, England.
Background: Children with disabilities worldwide experience disparities in oral health. Parents and children encounter challenges in accessing quality dental care. Similar challenges are experienced in Saudi Arabia.
View Article and Find Full Text PDFJ Clin Transl Sci
October 2024
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Efficient evidence generation to assess the clinical and economic impact of medical therapies is critical amid rising healthcare costs and aging populations. However, drug development and clinical trials remain far too expensive and inefficient for all stakeholders. On October 25-26, 2023, the Duke Clinical Research Institute brought together leaders from academia, industry, government agencies, patient advocacy, and nonprofit organizations to explore how different entities and influencers in drug development and healthcare can realign incentive structures to efficiently accelerate evidence generation that addresses the highest public health needs.
View Article and Find Full Text PDFLancet
December 2024
US National Academy of Medicine, Washington, DC, USA.
As the beginning of the next US presidential administration approaches, the USA faces a series of complex challenges that threaten the health of the American people and the effectiveness and sustainability of their health and health-care systems. Taking office in January, 2025, the next administration will need to address myriad systems-level and public health challenges, including the long-term health impacts of COVID-19 and threat of future pandemics, negative effects of climate change on health, unaffordability and inefficiencies in health care, and resulting and long-standing disparities in health-care access and health outcomes. Without decisive policy action, population health is likely to stagnate or even deteriorate.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!